Oxford Industries opened higher at $28.81, compared with its previous close of $28.63. In the last trading session, the stock traded between $27.93 and $29.20. It showed a downward intraday trend.
return calculator
Time Period
An investment of $100 made 5 years ago in Oxford Industries is now worth
$ 30.14
resulting in a loss of
$ 69.86 (69.86%)
invest with $1
Note: Past profits do not guarantee future returns.
Analyst Overview
Rating from 6 Analysts
Buy
0%
Hold
100%
Sell
0%
Markets Today
Today's Change
$-0.68 (-2.38%)
Day High
$29.20
Day Low
$27.93
Day Open
$28.81
Prev Close
$28.63
Volume
3,02,567
1W Return
-1.43%
1M Return
11.80%
3M Return
-28.18%
6M Return
-32.11%
1Y Return
-25.66%
Fundamentals
Market Cap ($ Mn)
419
PE Ratio
-
PB Ratio
1.09
PEG Ratio
-
ROE
-4.88%
ROCE
-2.94%
EPS (TTM)
$3.27
Investment Returns
1 Week
-1.43%
1 Month
11.80%
3 Months
-28.18%
6 Months
-32.11%
9 Months
-23.51%
Financials
Quarterly
All values in $ Mn
392.9
Apr 25
403.1
Jul 25
307.3
Oct 25
374.5
Jan 26
391.4
Apr 26
394.4
Jul 26
Updates
21Aug
Oxford Industries to release Q2FY26 results on September 3
Oxford Industries plans to release Q2FY26 results after market close on Sept 3, 2026. CEO Thomas Chubb and CFO Scott Grassmyer will host a post-earnings conference call at 4:30 p.m. ET. Live webcast and replay available via company website through Sept 17, 2026. Phone replay accessible via dial-in number with specific access code.
2mo ago
8Jul
Pomerantz investigates Oxford Industries after guidance cut
Pomerantz LLP has launched an investigation into Oxford Industries, Inc. regarding potential securities fraud following a drastic cut in revenue guidance. The firm is examining whether officers or directors engaged in unlawful business practices after the company's stock dropped 17.01% on June 11, 2026. Affected investors are urged to come forward to join the class action.
3mo ago
24Jun
Pomerantz investigates Oxford Industries after guidance cut
Pomerantz LLP is investigating Oxford Industries, Inc. for potential securities fraud following a 17% stock decline after the company cut its FY 2026 revenue guidance midpoint to $1.49 billion. The investigation focuses on whether officers and directors misled investors, particularly given prior optimistic statements and recent executive stock sales.
